EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Implications of Microbiota and Immune System in Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease

Jelena Popov iD, Tijana Despot, David Avelar Rodriguez iD, Irfan Khan, Eugene Mech iD, Mahrukh Khan iD, Milan Bojadzija, Nikhil Pai iD

Nutrients · 2024

DOI: 10.3390/nu16111668 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, 2024. Verfasst von Jelena Popov und 7 weiteren Autor:innen. Beteiligte Einrichtung: Boston Combined Residency Program, Boston Children's Hospital & Boston Medical Center, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Disease Progression. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent type of liver disease worldwide. The exact pathophysiology behind MASLD remains unclear; however, it is thought that a combination of factors or “hits” act as precipitants for disease onset and progression. Abundant evidence supports the roles of diet, genes, metabolic dysregulation, and the intestinal microbiome in influencing the accumulation of lipids in hepatocytes and subsequent progression to inflammation and fibrosis. Currently, there is no cure for MASLD, but lifestyle changes have been the prevailing cornerstones of management. Research is now focusing on the intestinal microbiome as a potential therapeutic target for MASLD, with the spotlight shifting to probiotics, antibiotics, and fecal microbiota transplantation. In this review, we provide an overview of how intestinal microbiota interact with the immune system to contribute to the pathogenesis of MASLD and metabolic dysfunction-associated steatohepatitis (MASH). We also summarize key microbial taxa implicated in the disease and discuss evidence supporting microbial-targeted therapies in its management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeDisease ProgressionHumansFecal Microbiota TransplantationImmune SystemProbioticsFatty LiverAnimalsNon-alcoholic Fatty Liver DiseaseAnti-Bacterial AgentsLiver

Stichwörter der Autor:innen

immunologymetabolic dysfunction-associated steatohepatitismetabolic dysfunction-associated steatotic liver diseasemetabolismmicrobiome

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Boston Combined Residency Program, Boston Children's Hospital & Boston Medical Center, Boston, MA 02115, USA.
  • College of Medicine and Health, University College Cork, T12 YN60 Cork, Ireland.
  • Department of Pediatric Gastroenterology, Hepatology & Nutrition, The Hospital for Sick Children, University of Toronto, Toronto, ON M5G 1E8, Canada.
  • School of Medicine, University College Dublin, D04 C1P1 Dublin, Ireland.
  • Department of Pediatrics, Faculty of Health Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada.
  • Department of Medical Sciences, Faculty of Health Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada.

ORCID-Profile: Jelena Popov, David Avelar Rodriguez, Eugene Mech, Mahrukh Khan, Nikhil Pai

Zitieren

APA

Popov, J., Despot, T., Avelar Rodriguez, D., Khan, I., Mech, E., Khan, M., Bojadzija, M., & Pai, N. (2024). Implications of Microbiota and Immune System in Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease. Nutrients. https://doi.org/10.3390/nu16111668

Vancouver

Popov J, Despot T, Avelar Rodriguez D, Khan I, Mech E, Khan M, et al. Implications of Microbiota and Immune System in Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease. Nutrients. 2024. doi:10.3390/nu16111668

BibTeX
@article{Popov2024,
  author = {Popov, Jelena and Despot, Tijana and Avelar Rodriguez, David and Khan, Irfan and Mech, Eugene and Khan, Mahrukh and Bojadzija, Milan and Pai, Nikhil},
  title = {Implications of Microbiota and Immune System in Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16111668}
}
Kostenlos starten →